Health-related quality of life and participation after inpatient rehabilitation of sepsis survivors with severe sequelae: a cohort study.


Journal

Journal of rehabilitation medicine
ISSN: 1651-2081
Titre abrégé: J Rehabil Med
Pays: Sweden
ID NLM: 101088169

Informations de publication

Date de publication:
02 Jul 2024
Historique:
received: 10 09 2023
accepted: 30 05 2024
medline: 3 7 2024
pubmed: 3 7 2024
entrez: 3 7 2024
Statut: epublish

Résumé

To describe health-related quality of life and participation after rehabilitation of severely affected sepsis survivors. Cohort study. Patients with severe sequelae after sepsis treated in a multidisciplinary rehabilitation pathway were included. Patient characteristics at the time of diagnosis, and the outcome 3 months after discharge from rehabilitation are described. At that time, health-related quality of life, social participation, and the rate of living at home were measured. Of the 498 patients enrolled, 100 severely impaired patients were transferred for a multidisciplinary rehabilitation approach. Fifty-five of them were followed up at 3 months. Descriptive and inference statistics showed that 69% were living at home with or without care. Health-related quality of life and participation scores were 0.64 ± 0.32 for the EQ-5D utility index and 54.98 ± 24.97 for the Reintegration of Normal Living Index. A multivariate regression model explaining health-related quality of life at 3 months included age, lower limb strength, and walking ability during rehabilitation (r2 = 0.5511). Participation at 3 months was explained by age, body mass index, lower limb strength, and duration of tracheal intubation (r2 = 0.6229). Patients who have experienced serious sepsis with severe sequelae can achieve a moderate level of quality of life and participation within a multidisciplinary pathway.

Identifiants

pubmed: 38956963
doi: 10.2340/jrm.v56.18670
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

jrm18670

Auteurs

Ulf Bodechtel (U)

Klinik Bavaria in Kreischa, Kreischa, Germany.

Thea Koch (T)

Klinik für Anästhesiologie und Intensivtherapie, Medizinische Fakultät 'Carl Gustav Carus', Technische Universität Dresden, Dresden, Germany.

Lars Heubner (L)

Klinik für Anästhesiologie und Intensivtherapie, Medizinische Fakultät 'Carl Gustav Carus', Technische Universität Dresden, Dresden, Germany.

Peter Spieth (P)

Klinik für Anästhesiologie und Intensivtherapie, Medizinische Fakultät 'Carl Gustav Carus', Technische Universität Dresden, Dresden, Germany.

Ines Rößler (I)

Klinik Bavaria in Kreischa, Kreischa, Germany.

Jan Mehrholz (J)

Wissenschaftliches Institut, Private Europäische Medizinische Akademie der Klinik Bavaria in Kreischa, Kreischa, Germany; Department of Public Health, Medizinische Fakultät 'Carl Gustav Carus', Technische Universität Dresden, Germany. jan.mehrholz@tu-dresden.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH